BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Shang RZ, Qu SB, Wang DS. Reprogramming of glucose metabolism in hepatocellular carcinoma: Progress and prospects. World J Gastroenterol 2016; 22(45): 9933-9943 [PMID: 28018100 DOI: 10.3748/wjg.v22.i45.9933]
URL: https://www.wjgnet.com/1948-5182/full/v22/i45/9933.htm
Number Citing Articles
1
Ting Zhang, Hong-Wei Gu, Jin-Xing Gao, Yu-Sang Li, He-Bin Tang. Ethanol supernatant extracts of Gynura procumbens could treat nanodiethylnitrosamine-induced mouse liver cancer by interfering with inflammatory factors for the tumor microenvironmentJournal of Ethnopharmacology 2022; 285: 114917 doi: 10.1016/j.jep.2021.114917
2
Zhihong Chen, Yiping Zou, Yuanpeng Zhang, Zhenrong Chen, Fan Wu, Ning Shi, Haosheng Jin. A novel prognostic signature based on four glycolysis‐related genes predicts survival and clinical risk of hepatocellular carcinomaJournal of Clinical Laboratory Analysis 2021; 35(11) doi: 10.1002/jcla.24005
3
Hepatitis C Virus Downregulates Core Subunits of Oxidative Phosphorylation, Reminiscent of the Warburg Effect in Cancer CellsCells 2019; 8(11): 1410 doi: 10.3390/cells8111410
4
Xiao Li, Yize Li, Shuang Bai, Jing Zhang, Zhengcai Liu, Jingyue Yang. NR2F1-AS1/miR-140/HK2 Axis Regulates Hypoxia-Induced Glycolysis and Migration in Hepatocellular CarcinomaCancer Management and Research 2021; : 427 doi: 10.2147/CMAR.S266797
5
Giulia Nannini, Gaia Meoni, Leonardo Tenori, Amedeo Amedei. Gastrointestinal Cancers: An Interdisciplinary ApproachInterdisciplinary Cancer Research 2023; 4: 69 doi: 10.1007/16833_2023_182
6
Jing An, Huixin He, Weiwei Yao, Yu Shang, Yun Jiang, Zhiqiang Yu. PI3K/Akt/FoxO pathway mediates glycolytic metabolism in HepG2 cells exposed to triclosan (TCS)Environment International 2020; 136: 105428 doi: 10.1016/j.envint.2019.105428
7
Nikolaus Berndt, Johannes Eckstein, Niklas Heucke, Tilo Wuensch, Robert Gajowski, Martin Stockmann, David Meierhofer, Hermann‐Georg Holzhütter. Metabolic heterogeneity of human hepatocellular carcinoma: implications for personalized pharmacological treatmentThe FEBS Journal 2021; 288(7): 2332 doi: 10.1111/febs.15587
8
Weicheng Wu, Xixi Zheng, Jing Wang, Tianxiao Yang, Wenjuan Dai, Shushu Song, Lan Fang, Yilin Wang, Jianxin Gu. O-GlcNAcylation on Rab3A attenuates its effects on mitochondrial oxidative phosphorylation and metastasis in hepatocellular carcinomaCell Death & Disease 2018; 9(10) doi: 10.1038/s41419-018-0961-7
9
Xiaonuan Luo, Yin Peng, Xinmin Fan, Xiaoxun Xie, Zhe Jin, Xiaojing Zhang. The Crosstalk and Clinical Implications of CircRNAs and Glucose Metabolism in Gastrointestinal CancersCancers 2023; 15(8): 2229 doi: 10.3390/cancers15082229
10
Le Liu, Liping Liang, Genghui Mai, Ye Chen. A novel fatty acid metabolism‐related gene signature predicts the prognosis, tumor immune properties, and immunotherapy response of colon adenocarcinoma patients FASEB BioAdvances 2022; 4(9): 585 doi: 10.1096/fba.2022-00017
11
Guizhi Jia, Yan Wang, Chengjie Lin, Shihui Lai, Hongliang Dai, Zhiqian Wang, Luo Dai, Huizhao Su, Yanjie Song, Naiwen Zhang, Yukuan Feng, Bo Tang. RETRACTED ARTICLE: LNCAROD enhances hepatocellular carcinoma malignancy by activating glycolysis through induction of pyruvate kinase isoform PKM2Journal of Experimental & Clinical Cancer Research 2021; 40(1) doi: 10.1186/s13046-021-02090-7
12
Jiaqi Yi, Xuehua Luo, Weijian Huang, Weijun Yang, Yan Qi, Jun He, Huijun Xie. PGK1 is a potential biomarker for early diagnosis and prognosis of hepatocellular carcinomaOncology Letters 2024; 27(3) doi: 10.3892/ol.2024.14242
13
F Pepe, S Pagotto, S Soliman, C Rossi, P Lanuti, C Braconi, R Mariani-Costantini, R Visone, A Veronese. Regulation of miR-483-3p by the O-linked N-acetylglucosamine transferase links chemosensitivity to glucose metabolism in liver cancer cellsOncogenesis 2017; 6(5): e328 doi: 10.1038/oncsis.2017.35
14
Shuangfeng Li, Shuangshuang Yin, Hui Ding, Yingying Shao, Shiyue Zhou, Weiling Pu, Lifeng Han, Tao Wang, Haiyang Yu. Polyphenols as potential metabolism mechanisms regulators in liver protection and liver cancer preventionCell Proliferation 2023; 56(1) doi: 10.1111/cpr.13346
15
Abdel-Hady A. Abdel-Wahab, Heba Effat, Engy A. Mahrous, Mennatallah A. Ali, Tamer A. Al-Shafie. A Licorice Roots Extract Induces Apoptosis and Cell Cycle Arrest and Improves Metabolism via Regulating MiRNAs in Liver Cancer Cells Nutrition and Cancer 2021; 73(6): 1047 doi: 10.1080/01635581.2020.1783329
16
Wei Li, Ji Hao, Lang Zhang, Zhuo Cheng, Xukun Deng, Guangwen Shu. Astragalin Reduces Hexokinase 2 through Increasing miR-125b to Inhibit the Proliferation of Hepatocellular Carcinoma Cells in Vitro and in VivoJournal of Agricultural and Food Chemistry 2017; 65(29): 5961 doi: 10.1021/acs.jafc.7b02120
17
Chunyan Liu, Xiuli Wang, Youzhong Zhang. The Roles of HK2 on Tumorigenesis of Cervical CancerTechnology in Cancer Research & Treatment 2019; 18: 153303381987130 doi: 10.1177/1533033819871306
18
Siyuan Wang, Yiling Li, Ning Liu, Wei Shen, Wenhao Xu, Peng Yao, Hongda Liu. Identification of Glucose Metabolism-Related Genes in the Progression from Nonalcoholic Fatty Liver Disease to Hepatocellular CarcinomaGenetics Research 2022; 2022: 1 doi: 10.1155/2022/8566342
19
Chaozhi Tang, Jiakang Ma, Xiuli Liu, Zhengchun Liu. Identification of a prognostic signature of nine metabolism-related genes for hepatocellular carcinomaPeerJ 2020; 8: e9774 doi: 10.7717/peerj.9774
20
Yuan-Yuan Chen, Wei-Hua Wang, Lin Che, You Lan, Li-Yin Zhang, Deng-Lin Zhan, Zi-Yan Huang, Zhong-Ning Lin, Yu-Chun Lin. BNIP3L-Dependent Mitophagy Promotes HBx-Induced Cancer Stemness of Hepatocellular Carcinoma Cells via Glycolysis Metabolism ReprogrammingCancers 2020; 12(3): 655 doi: 10.3390/cancers12030655
21
Jun Chen, Evan LaGue, Junjie Li, Chendong Yang, Edward P. Hackett, Manuel Mendoza, Jeffry R. Alger, Ralph J. DeBerardinis, Ian R. Corbin, Kelvin L. Billingsley, Jae Mo Park. Profiling Carbohydrate Metabolism in Liver and Hepatocellular Carcinoma with [13C]‐Glycerate ProbesAnalysis & Sensing 2021; 1(4): 196 doi: 10.1002/anse.202100034
22
Dan-Hong Yang, Wei-Ping Wang, Qiang Zhang, Hong-Ying Pan, Yi-Cheng Huang, Jia-Jie Zhang. Hepatocellular carcinoma progression in hepatitis B virus-related cirrhosis patients receiving nucleoside (acid) analogs therapy: A retrospective cross-sectional studyWorld Journal of Gastroenterology 2021; 27(17): 2025-2038 doi: 10.3748/wjg.v27.i17.2025
23
Suzan Attia Mawed, Yan He, Jin Zhang, Jie Mei. Strategy of Hepatic Metabolic Defects Induced by beclin1 Heterozygosity in Adult ZebrafishInternational Journal of Molecular Sciences 2020; 21(4): 1533 doi: 10.3390/ijms21041533
24
Hiroyuki Hachiya, Taku Aoki, Yukihiro Iso, Takayuki Shimizu, Kazuma Tago, Kyung Hwa Park, Yuhki Sakuraoka, Takayuki Shiraki, Shozo Mori, Keiichi Kubota. Effects of branched‐chain amino acids on postoperative tumor recurrence in patients undergoing curative resection for hepatocellular carcinoma: A randomized clinical trialJournal of Hepato-Biliary-Pancreatic Sciences 2020; 27(11): 819 doi: 10.1002/jhbp.830
25
Tao Zhang, Yaogang Zhang, Zihan Yang, Yuan Jiang, Li Sun, Dengliang Huang, Meiyuan Tian, Yinhong Shen, Jun Deng, Jing Hou, Yanyan Ma. Echinococcus multilocularis protoscoleces enhance glycolysis to promote M2 Macrophages through PI3K/Akt/mTOR Signaling Pathway Pathogens and Global Health 2023; 117(4): 409 doi: 10.1080/20477724.2022.2104055
26
Gebing Yao, Jikai Yin, Qing Wang, Rui Dong, Jianguo Lu. Glypican-3 Enhances Reprogramming of Glucose Metabolism in Liver Cancer CellsBioMed Research International 2019; 2019: 1 doi: 10.1155/2019/2560650
27
Hengdong Qu, Junli Liu, Di Zhang, Ruoyan Xie, Lijuan Wang, Jian Hong. Glycolysis in Chronic Liver Diseases: Mechanistic Insights and Therapeutic OpportunitiesCells 2023; 12(15): 1930 doi: 10.3390/cells12151930
28
Stavros P. Papadakos, Daniele Ferraro, Gabriele Carbone, Adam Enver Frampton, Giovanni Vennarecci, Stylianos Kykalos, Dimitrios Schizas, Stamatios Theocharis, Nikolaos Machairas. The Emerging Role of Metformin in the Treatment of Hepatocellular Carcinoma: Is There Any Value in Repurposing Metformin for HCC Immunotherapy?Cancers 2023; 15(12): 3161 doi: 10.3390/cancers15123161
29
Dezhi Li, Xianyi Cheng, Wei Zheng, Junhui Chen. <p>Glucosamine-6-Phosphate Isomerase 1 Promotes Tumor Progression and Indicates Poor Prognosis in Hepatocellular Carcinoma</p>Cancer Management and Research 2020; : 4923 doi: 10.2147/CMAR.S250094
30
Kashif Rafiq Zahid, Shun Yao, Abdur Rehman Raza Khan, Umar Raza, Deming Gou. mTOR/HDAC1 Crosstalk Mediated Suppression of ADH1A and ALDH2 Links Alcohol Metabolism to Hepatocellular Carcinoma Onset and Progression in silicoFrontiers in Oncology 2019; 9 doi: 10.3389/fonc.2019.01000
31
Chenchen Wang, Ying Tong, Yankai Wen, Jie Cai, Han Guo, Lifeng Huang, Min Xu, Mingxuan Feng, Xiaosong Chen, Jianjun Zhang, Hailong Wu, Xiaoni Kong, Qiang Xia. Hepatocellular Carcinoma‐Associated Protein TD26 Interacts and Enhances Sterol Regulatory Element‐Binding Protein 1 Activity to Promote Tumor Cell Proliferation and GrowthHepatology 2018; 68(5): 1833 doi: 10.1002/hep.30030
32
Somasekhara Derangula, Varalakshmi Kilingar Nadumane. Analysis of the Anticancer Mechanism of OR3 Pigment from Streptomyces coelicolor JUACT03 Against the Human Hepatoma Cell Line Using a Proteomic ApproachCell Biochemistry and Biophysics 2024;  doi: 10.1007/s12013-024-01258-0
33
Fei-Fei Cai, Ya-Nan Song, Yi-Yu Lu, Yongyu Zhang, Yi-Yang Hu, Shi-Bing Su. Analysis of plasma metabolic profile, characteristics and enzymes in the progression from chronic hepatitis B to hepatocellular carcinomaAging 2020; 12(14): 14949 doi: 10.18632/aging.103554
34
Jiao Feng, Jingjing Li, Liwei Wu, Qiang Yu, Jie Ji, Jianye Wu, Weiqi Dai, Chuanyong Guo. Emerging roles and the regulation of aerobic glycolysis in hepatocellular carcinomaJournal of Experimental & Clinical Cancer Research 2020; 39(1) doi: 10.1186/s13046-020-01629-4
35
Yiwei Xu, Xiaodong Hao, Yidan Ren, Qinchen Xu, Xiaoyan Liu, Shuliang Song, Yunshan Wang. Research progress of abnormal lactate metabolism and lactate modification in immunotherapy of hepatocellular carcinomaFrontiers in Oncology 2023; 12 doi: 10.3389/fonc.2022.1063423
36
Ya‐Jie Hu, Xu Zhang, Hong‐Ming Lv, Yang Liu, Shi‐Ze Li. Protein O‐GlcNAcylation: The sweet hub in liver metabolic flexibility from a (patho)physiological perspectiveLiver International 2024; 44(2): 293 doi: 10.1111/liv.15812
37
Xiaolong Chen, Zhixiong Xia, Yafeng Wan, Ping Huang. Identification of hub genes and candidate drugs in hepatocellular carcinoma by integrated bioinformatics analysisMedicine 2021; 100(39): e27117 doi: 10.1097/MD.0000000000027117
38
Monica Mossenta, Davide Busato, Michele Dal Bo, Giuseppe Toffoli. Glucose Metabolism and Oxidative Stress in Hepatocellular Carcinoma: Role and Possible Implications in Novel Therapeutic StrategiesCancers 2020; 12(6): 1668 doi: 10.3390/cancers12061668
39
Wenwei Liao, Jinpeng Du, Zhen Wang, Qingbo Feng, Mingheng Liao, Huixian Liu, Kefei Yuan, Yong Zeng. The role and mechanism of noncoding RNAs in regulation of metabolic reprogramming in hepatocellular carcinomaInternational Journal of Cancer 2022; 151(3): 337 doi: 10.1002/ijc.34040
40
Rong Zhou, Wen Ni, Chao Qin, Yunxia Zhou, Yuqing Li, Jianping Huo, Lijuan Bian, Aijun Zhou, Jianming Li. A functional loop between YTH domain family protein YTHDF3 mediated m6A modification and phosphofructokinase PFKL in glycolysis of hepatocellular carcinomaJournal of Experimental & Clinical Cancer Research 2022; 41(1) doi: 10.1186/s13046-022-02538-4
41
Junjie Kong, Tao Wang, Shu Shen, Zifei Zhang, Xianwei Yang, Wentao Wang. A genomic-clinical nomogram predicting recurrence-free survival for patients diagnosed with hepatocellular carcinomaPeerJ 2019; 7: e7942 doi: 10.7717/peerj.7942
42
Kanchan Vishnoi, Sandeep Kumar, Rong Ke, Ajay Rana, Basabi Rana. Dysregulation of immune checkpoint proteins in hepatocellular carcinoma: Impact on metabolic reprogrammingCurrent Opinion in Pharmacology 2022; 64: 102232 doi: 10.1016/j.coph.2022.102232
43
Serena De Matteis, Andrea Ragusa, Giorgia Marisi, Stefania De Domenico, Andrea Casadei Gardini, Massimiliano Bonafè, Anna Maria Giudetti. Aberrant Metabolism in Hepatocellular Carcinoma Provides Diagnostic and Therapeutic OpportunitiesOxidative Medicine and Cellular Longevity 2018; 2018: 1 doi: 10.1155/2018/7512159
44
Shi-Lei Wang, Yu Wang, Lei Wu, Yuan-Yuan Cai, Zi-Chao Wang, Raphael N. Alolga, Lian-Wen Qi, Bin Li, Feng-Qing Huang. Paired Derivatization Approach with H/D-Labeled Hydroxylamine Reagents for Sensitive and Accurate Analysis of Monosaccharides by Liquid Chromatography Tandem Mass SpectrometryAnalytical Chemistry 2022; 94(8): 3590 doi: 10.1021/acs.analchem.1c04924
45
Shan Cong, shanshan Bai, Minghao Zhang, yanfang Bi, yu Wang, shi Jin, hui He. A study on metabolic characteristics and metabolic markers of gastrointestinal tumorsCancer Biology & Therapy 2023; 24(1) doi: 10.1080/15384047.2023.2255369
46
Chao Liu, Renwei Huang, Han Yu, Yanju Gong, Peijie Wu, Quansheng Feng, Xia Li. Fuzheng Xiaozheng prescription exerts anti-hepatocellular carcinoma effects by improving lipid and glucose metabolisms via regulating circRNA-miRNA-mRNA networksPhytomedicine 2022; 103: 154226 doi: 10.1016/j.phymed.2022.154226
47
Yuanyuan Zhao, Gang Ye, You Wang, Dan Luo. MiR-4461 Inhibits Tumorigenesis of Renal Cell Carcinoma by Targeting PPP1R3CCancer Biotherapy and Radiopharmaceuticals 2022; 37(6): 503 doi: 10.1089/cbr.2020.3846
48
Xinxu Min, Hao Cheng, Xiaofei Cao, Ziyang Chen, Xiaojin Zhang, Yunfan Li, Qian Mao, Bin Xue, Lei Fang, Li Liu, Zhengnian Ding. Heat shock protein A12A activates migration of hepatocellular carcinoma cells in a monocarboxylate transporter 4–dependent mannerCell Stress and Chaperones 2022; 27(1): 83 doi: 10.1007/s12192-021-01251-z
49
Sheraz Ahmad Bhat, Zeenat Farooq, Hagar Ismail, Irene Corona-Avila, Md. Wasim Khan. Unraveling the Sweet Secrets of HCC: Glucometabolic Rewiring in Hepatocellular CarcinomaTechnology in Cancer Research & Treatment 2023; 22 doi: 10.1177/15330338231219434
50
Flora Yang, Leena Hilakivi-Clarke, Aurpita Shaha, Yuanguo Wang, Xianghu Wang, Yibin Deng, Jinping Lai, Ningling Kang. Metabolic reprogramming and its clinical implication for liver cancerHepatology 2023; 78(5): 1602 doi: 10.1097/HEP.0000000000000005
51
Yunong Fu, Kaibo Yang, Kunjin Wu, Hai Wang, Qinglin Li, Fengping Zhang, Kun Yang, Qing Yao, Xiaohua Ma, Yujie Deng, Jingyao Zhang, Chang Liu, Kai Qu. Identification of hepatocellular carcinoma subtypes based on PcG-related genes and biological relevance with cancer cellsClinical Epigenetics 2022; 14(1) doi: 10.1186/s13148-022-01393-6
52
Rosendo García-Carrillo, Francisco A. Molina-Pelayo, David Zarate-Lopez, Alejandro Cabrera-Aguilar, Bibiana Ortega-Domínguez, Mariana Domínguez-López, Natalia Chiquete-Félix, Adan Dagnino-Acosta, Gabriela Velasco-Loyden, Enrique Chávez, Luis Castro-Sánchez, Victoria Chagoya de Sánchez. An adenosine derivative promotes mitochondrial supercomplexes reorganization and restoration of mitochondria structure and bioenergetics in a diethylnitrosamine-induced hepatocellular carcinoma modelScientific Reports 2024; 14(1) doi: 10.1038/s41598-024-56306-9
53
Mrigendra B. Karmacharya, Laith R. Sultan, Chandra M. Sehgal. Photoacoustic monitoring of oxygenation changes induced by therapeutic ultrasound in murine hepatocellular carcinomaScientific Reports 2021; 11(1) doi: 10.1038/s41598-021-83439-y
54
Israa T. Ismail, Oliver Fiehn, Ashraf Elfert, Marwa Helal, Ibrahim Salama, Hala El-Said. Sugar Alcohols Have a Key Role in Pathogenesis of Chronic Liver Disease and Hepatocellular Carcinoma in Whole Blood and Liver TissuesCancers 2020; 12(2): 484 doi: 10.3390/cancers12020484
55
Jian Xue, Feng Pan, Tengcong Long, Frank Shujie Hou. Glycosylated triptolide affords a potent in vivo therapeutic activity to hepatocellular carcinoma in mouse modelMedicinal Chemistry Research 2023; 32(2): 254 doi: 10.1007/s00044-022-03008-4
56
Jiabin Yang, Liangtang Zeng, Ruiwan Chen, Shangyou Zheng, Yu Zhou, Rufu Chen. Characterization of heterogeneous metabolism in hepatocellular carcinoma identifies new therapeutic target and treatment strategyFrontiers in Immunology 2023; 14 doi: 10.3389/fimmu.2023.1076587
57
Romain Désert, Natalia Nieto, Orlando Musso. Dimensions of hepatocellular carcinoma phenotypic diversityWorld Journal of Gastroenterology 2018; 24(40): 4536-4547 doi: 10.3748/wjg.v24.i40.4536
58
Chuanzong Zhao, Ben Wang, Enyu Liu, Zongli Zhang. Loss of PTEN expression is associated with PI3K pathway-dependent metabolic reprogramming in hepatocellular carcinomaCell Communication and Signaling 2020; 18(1) doi: 10.1186/s12964-020-00622-w
59
Bahare Shokouhian, Babak Negahdari, Zahra Heydari, Mehdi Totonchi, Hamidreza Aboulkheyr Es, Abbas Piryaei, Ebrahim Mostafavi, Massoud Vosough. HNF4α is possibly the missing link between epithelial–mesenchymal transition and Warburg effect during hepatocarcinogenesisCancer Science 2023; 114(4): 1337 doi: 10.1111/cas.15686
60
Curtis C. Hughey, Elijah Trefts, Deanna P. Bracy, Freyja D. James, E. Patrick Donahue, David H. Wasserman. Glycine N-methyltransferase deletion in mice diverts carbon flux from gluconeogenesis to pathways that utilize excess methionine cycle intermediatesJournal of Biological Chemistry 2018; 293(30): 11944 doi: 10.1074/jbc.RA118.002568
61
Yongmei Li, Hao Zhuang, Xinran Zhang, Yuan Li, Yun Liu, Xianfu Yi, Guoxuan Qin, Wen Wei, Ruibing Chen. Multiomics Integration Reveals the Landscape of Prometastasis Metabolism in Hepatocellular CarcinomaMolecular & Cellular Proteomics 2018; 17(4): 607 doi: 10.1074/mcp.RA118.000586
62
Zhipeng Sun, Guangyang Chen, Liang Wang, Qing Sang, Guangzhong Xu, Nengwei Zhang. APEX1 promotes the oncogenicity of hepatocellular carcinoma via regulation of MAP2K6Aging 2022; 14(19): 7959 doi: 10.18632/aging.204325
63
Marina Serra, Amedeo Columbano, Andrea Perra, Marta Anna Kowalik. Animal Models: A Useful Tool to Unveil Metabolic Changes in Hepatocellular CarcinomaCancers 2020; 12(11): 3318 doi: 10.3390/cancers12113318
64
Hester van Mourik, Mengying Li, Sabine Baumgartner, Jan Theys, Ronit Shiri-Sverdlov. All Roads Lead to Cathepsins: The Role of Cathepsins in Non-Alcoholic Steatohepatitis-Induced Hepatocellular CarcinomaBiomedicines 2022; 10(10): 2351 doi: 10.3390/biomedicines10102351
65
Qi Wang, Juan Liu, Ziye Chen, Jingjing Zheng, Yunfang Wang, Jiahong Dong. Targeting metabolic reprogramming in hepatocellular carcinoma to overcome therapeutic resistance: A comprehensive reviewBiomedicine & Pharmacotherapy 2024; 170: 116021 doi: 10.1016/j.biopha.2023.116021
66
Se‐Lim Kim, Soo Teik Lee, In Suk Min, Young Ran Park, Ju Hyung Lee, Dae‐Ghon Kim, Sang‐Wook Kim. Lipocalin 2 negatively regulates cell proliferation and epithelial to mesenchymal transition through changing metabolic gene expression in colorectal cancerCancer Science 2017; 108(11): 2176 doi: 10.1111/cas.13389
67
Yeliz Yılmaz, Ayşim Güneş, Hande Topel, Neşe Atabey. Signaling Pathways as Potential Therapeutic Targets in HepatocarcinogenesisJournal of Gastrointestinal Cancer 2017; 48(3): 225 doi: 10.1007/s12029-017-9958-1
68
Qi Zhang, Yu Lou, Xue-Li Bai, Ting-Bo Liang. Immunometabolism: A novel perspective of liver cancer microenvironment and its influence on tumor progressionWorld Journal of Gastroenterology 2018; 24(31): 3500-3512 doi: 10.3748/wjg.v24.i31.3500
69
Georgios A. Kaissis, Fabian K. Lohöfer, Marie Hörl, Irina Heid, Katja Steiger, Kim Agnes Munoz-Alvarez, Markus Schwaiger, Ernst J. Rummeny, Wilko Weichert, Philipp Paprottka, Rickmer Braren. Combined DCE-MRI- and FDG-PET enable histopathological grading prediction in a rat model of hepatocellular carcinomaEuropean Journal of Radiology 2020; 124: 108848 doi: 10.1016/j.ejrad.2020.108848
70
Huining Tian, Xiaoyu Zhu, You Lv, Yan Jiao, Guixia Wang. <p>Glucometabolic Reprogramming in the Hepatocellular Carcinoma Microenvironment: Cause and Effect</p>Cancer Management and Research 2020; : 5957 doi: 10.2147/CMAR.S258196
71
Quan-Hong Qin, Zhi-Qi Yin, Yan Li, Bao-Gui Wang, Ming-Fang Zhang. Long intergenic noncoding RNA 01296 aggravates gastric cancer cells progress through miR-122/MMP-9Biomedicine & Pharmacotherapy 2018; 97: 450 doi: 10.1016/j.biopha.2017.10.066
72
Fengmei Zhang, Jing Wu, Lei Zhang, Jian Zhang, Rui Yang. Alterations in serum metabolic profiles of early-stage hepatocellular carcinoma patients after radiofrequency ablation therapyJournal of Pharmaceutical and Biomedical Analysis 2024; 243: 116073 doi: 10.1016/j.jpba.2024.116073
73
Sapna Sharma, Jennifer Kriebel, Harald Grallert. Epigenetic regulation of glucose metabolismCurrent Opinion in Clinical Nutrition & Metabolic Care 2017; 20(4): 266 doi: 10.1097/MCO.0000000000000375
74
Haiying Xu, Lanqing Li, Shunshun Wang, Zijun Wang, Linghang Qu, Chunli Wang, Kang Xu. Royal jelly acid suppresses hepatocellular carcinoma tumorigenicity by inhibiting H3 histone lactylation at H3K9la and H3K14la sitesPhytomedicine 2023; 118: 154940 doi: 10.1016/j.phymed.2023.154940
75
Weizheng Wu, Kunming Wen. Research progress on the interaction between long non‑coding RNAs and RNA‑binding proteins to influence the reprogramming of tumor glucose metabolism (Review)Oncology Reports 2022; 48(3) doi: 10.3892/or.2022.8365